Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Forum Markets, Incorporated

FRMMNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 14, 2026Accepted Aug 14, 2026, 4:15 PM EDTFiling CIK 1690080Accession 0001213900-26-090081
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-08-01
Issuer
FORUM MARKETS Inc
Issuer CIK
0001690080
Trading symbol
FRMM

Reporting owner 1

Name
Saunders John Tazewell
Reporting owner CIK
0002099143
Relationship
Officer
Officer title
Chief Financial Officer
Address
2875 SOUTH OCEAN BLVD, SUITE 200, PALM BEACH, FL, 33480

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-08-01F · Form 416,151[F1]D5.16342,441D
Table key
F · Form 4
Securities delivered or withheld for exercise price or tax liability under Rule 16b-3
D
Direct

Footnotes

F1
The transaction reported represents the forfeiture of shares to the Issuer, valued based on the closing price of the stock on the vesting date, to satisfy the Reporting Person's tax withholding obligations arising from the vesting and settlement of restricted stock units originally granted on April 2, 2026, and does not represent a discretionary sale by the Reporting Person. The shares were officially issued on August 14, 2026.↩ 1

Signature 1

Signed
/s/ John Saunders
Date
2026-08-14

Company context

We were formed as a clinical stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy. In September 2024, we completed the acquisition of certain source code and intellectual property relating to an online blockchain casino, and moving forward, we plan to focus the majority of our operations on the creation of the online blockchain casino, while looking to monetize certain prior development stage therapeutic product candidates for unmet medical needs.

Current securities

Historical securities (4)

Recent company filings

  1. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Regulation FD Disclosure · Other EventsOct 5, 2026
  2. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 21, 2026
  3. Submission of Matters to a Vote of Security HoldersAug 19, 2026
  4. SCHEDULE 13G/A - filed by Cyber Citadel regarding FORUM MARKETS IncAug 14, 2026
  5. 4 filingAug 14, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.